Disruption in Healthcare: Amazon, Brexit, Trump, MACRA, Gig Workers, Aging - 27 Factors That Could Change the Business

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,995	98 Pages	Kalorama Information	March, 2018	KLI15634024

Best Price Guarantee
Price	from $2,995
Length	98 Pages
Publisher	Kalorama Information
Published Date	March, 2018
SKU	KLI15634024

In healthcare, there are 27 potential disruptors that could have a large impact on the market. This report discusses them and how they will impact markets in healthcare and pharmaceuticals:

• New US Healthcare Policies/ACA Status

• Reimbursement Changes in Europe and Other Developed Nations

• Brexit

• Emerging Countries

• Demographic Changes

• Ransomware and Blockchain Strategies

• Telemedicine

• Walk-in Clinics

• MACRA

• Empowered Consumers

• "Gig" Economy

• Value-Based Reimbursement

• Brazilian Biotech Market

• Healthcare in China

• Association Healthcare Plans

• Brazil as a Significant Pharma Player

• Technology Advances

• Physician Shortages, Advanced Nurse Surplus

• Changes in Drug Sourcing

• Mergers and Acquisitions

• IPO and Venture Investment

• And Others…

This report details current challenges and upending factors in healthcare markets globally. It also processes these developments into useful market forecasts in overall healthcare and pharmaceuticals specifically, in 18 ten-year forecast tables.

From the report:

Empowered Healthcare Consumers - The Internet has dramatically increased the availability of medical, health and wellness information for consumers in virtually all world markets. As of early 2018, almost 4 billion people used the Internet, representing over 52% of the world’s population. Usage is highest in North America and Europe, with about 90% and 80% of the population online, respectively. While just 32% of Africa is online and about 48% of Asia, these proportions are expected to increase strongly over the next several years. As a result, consumers are easily able to access:

• health and wellness information in online publications, platforms and communities;

• provider (physician, hospital, lab, insurance) websites and information.

As a result, patients are becoming better educated and informed. By learning about the availability of healthcare products and services in other areas and connecting with other providers, they are also increasing competition in the marketplace.

MACRA and Value Based Reimbursement - Also known as Quality-Based Reimbursement, VBR is a means to compensate care providers in a way that ties payments to the quality of care provided while rewarding providers for efficiency and effectiveness. It is an alternative to fee-for-service (FFS) reimbursement which pays providers for services delivered based on bill charges or annual fee schedules.

The “Gig Economy” is a relatively new term that refers to the growing shift away from fulltime employment towards part time, temporary and/or project work as a means to earn income. These two forms of professional activity are structured quite differently although both forms may be utilized to perform similar functions – ie. some workers in a particular company or profession may be characterized as fulltime, while others may be legally characterized as temporary or project workers.

Increasing and Aging Populations - Over the past 50 years, the world’s population has expanded significantly and over the next decade, this growth is expected to continue. The total population expanded by 1.14% per year from 6.8 billion in 2008 to more than 7.6 billion in 2018 and is expected to exceed 8.5 billion by 2028. Greatest growth will occur in Africa at an estimated 2.55% per year, followed by Oceana at 1.43% per year and Asia at 0.94% annually.

Trump Administration Positions and New Policies -In December 2017, President Trump signed a bill repealing the Individual Mandate of the ACA beginning in 2019. The mandate is a core component of the Affordable Care Act and fines people who do not have health insurance. For tax year 2017, this fine is either 2.5% of the individual’s total household income, or $695 per uninsured adult and $347.50 per uninsured child (up to a maximum of $2,085), whichever figure is higher. But the tax bill leaves every other major component of the ACA intact.

Kalorama Analysis: Processing the 27 Factors into Market Forecasts

Kalorama Information's Unique report takes a look at these factors and how they could impact pharmaceutical and healthcare markets. The report includes the following forecasts:

• Global Healthcare Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario

• U.S. Healthcare Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario

• Europe Healthcare Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario

• Global Pharmaceutical Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario

• U.S. Pharmaceutical Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario

• Europe Pharmaceutical Market, 2017-2027 -Worst Case/Best Case/Most Like Case Scenario

Executive Summary
- The Global Healthcare Industry
- Scope and Methodology
Overview
- Introduction
- Factor One: Global Demographic Shifts
  - Global Population Growth and Aging
    - Table Total Global Population by Region, 2008 - 2028, in Millions
    - Table Global Population of People Age 60 and Older by Region, 2008 - 2028, in Millions
  - Obesity
- Factor Two: The Gig Economy
  - Table Key Characteristics of Employment vs. Gig Workers, 2018
  - Table Risks and Rewards of Employment vs. Gig Work, 2018
- Factor Three: Pace of Technology Advancements Increase
- Global Healthcare Trends
- Factor Three: Rising Rates of Disease Diagnosis and Treatment
- Factor Four: Growing U.S. Out of Pocket Spending on Healthcare
- Factor Five: Alternative Therapies and Energy Medicine
- Factor Six: Healthcare IPO Boom
  - Table Total and Healthcare Global IPO Deal Volume, 2012 - 2017
  - Table Total and Healthcare Global IPO Deal Value, 2012 - 2017, In $Billions
- Factor Seven: Mergers and Acquisitions
  - Table Total U.S. Healthcare M&A Deal Value, 2009 - 2017, in $Billions
  - Table Selected Recent Healthcare M&A Activity
  - Product Launches
- Factor Eight: Bitcoin and Blockchain
- Factor Nine: Amazon and the New Healthcare Behemoths
- Factor Ten: Threats of War
Key Issues: U.S.
- Introduction
- Factor Eleven: Affordable Care Act Changes/Individual Mandate Repeal
  - Individual Mandate Repeal
- Factor Twelve: Association Healthcare Plans
  - Total Repeal
  - Further Changes to the ACA
- Factor Thirteen: MACRA, PAMA and Reimbursement Changes
  - MACRA and Value Based Reimbursement
- Factor Fourteen - Remote Patient Monitoring and Telehealth
- Factor Fifteen: Hospital Production of Generic Medicines
- Factor Sixteen: Legalization of Marijuana
  - Table Current and Recently-Approved State Laws Legalizing Marijuana for Medical or Recreational Purposes, Q1 2018
  - Table Federal Penalties for Marijuana Possession, Sale, Cultivation & Paraphernalia, 2018
- Factor Seventeen 2017 Tax Reform Legislation Consequences
- Factor Eighteen: Physician Shortage, NP Surplus
  - Physician Shortage
  - Advanced Practice Nurse Surplus
  - Older Workers
- Factor Nineteen: Urgent Care and Retail Clinics
  - Urgent Care Centers
  - Retail Clinics
  - Other Healthcare Venues
- Factor Twenty: U.S. Opioid Crisis
- Factor Twenty-One: Ransomware and Cybercrime
Key Issues: Europe
- Introduction
  - Table Key Indicators: Western Europe, Eastern Europe, Switzerland, Russia, 2017
  - Economic Rebound in the Eurozone
- Factor Twenty-Two: Brexit
- Factor Twenty-Three: Austerity
  - UK
- Factor Twenty-Four: Bailout EU Nations: Greece, Ireland, Portugal, Spain, Cypress
  - Technology Laggership in Europe
  - High Costs of Doing Business
Key Issues: Emerging Markets
- Introduction
  - Table Characteristics of Tier I, II and III Players, 2017
- Factor Twenty Five: Developed Nations Turn to Biotech
  - Table Key Indicators: Tier I Countries, 2017
  - Growing Pharma and Biotech Industries
- Factor Twenty-Six: Rise of Eastern Europe
  - China and India
    - Table Key Indicators: Tier II Countries, 2017
  - Changing Disease Patterns
- Factor Twenty-Seven: China/India Healthcare Reform, Brazil Pharma Reform
  - Table Key Healthcare Reforms and Remaining Current Gaps in China and India, 1997 - 2017
  - Intellectual Property Struggles
  - Corporate Incentives
  - China and India Focus on Biotech
  - Shift from Generics to Innovative Products
  - Outsourcing Boom
  - Tier III Countries
  - Brazil Pharma's Boom
  - Political and Economic Instability
Considering the 27 Factors - Best/Worst/Moderate Case Market Forecasts
- Overview
- Total Healthcare Market Forecasts
  - Table Total Global Healthcare Market in $ Billions, Historic, Best Case, Most Likely & Worst Case, 2007 - 2027, in $Billions
  - Table Total Global Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
  - U.S. Healthcare Market
    - Table Total U.S. Healthcare Market, Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
    - Table Total Global Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
  - Europe Healthcare Market
    - Table Total European Healthcare Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
    - Table Total European Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
  - Asia Healthcare Market
    - Table Total Asian Healthcare Market: Best Case, Most Likely & Worst Case, 2007 - 2027($BN)
    - Table Total Asian Healthcare Market Growth for Best Case, Most Likely & Worst Case, 2017 2027, in $Billions
- Total Pharmaceutical Market Forecasts
  - Table Total Global Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
  - Table Total Global Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
  - U.S. Pharmaceutical Market
    - Table U.S. Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
    - Table Total U.S. Biopharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
  - Europe Pharmaceutical Market
    - Table European Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
    - Table Total European Pharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions
  - Asia Pharmaceutical Market
    - Table Asian Pharmaceutical Market: Best Case, Most Likely & Worst Case, 2007 - 2027 ($BN)
    - Table Total Asian Pharmaceutical Market Growth for Best Case, Most Likely & Worst Case, 2017 - 2027, in $Billions